Generated by All in One SEO v4.9.9, this is an llms.txt file, used by LLMs to index the site.

# Multiomic Health

AI-Enabled Precision Medicine for Metabolic Syndrome

## Sitemaps

- [XML Sitemap](https://multiomic.health/sitemap.xml): Contains all public & indexable URLs for this website.

## Posts

- [News.](https://multiomic.health/news/)
- [MultiOmic Health and BIO4 Campus Sign MoU to Advance Precision Medicine and Support Bioeconomy Growth in Serbia](https://multiomic.health/multiomic-health-and-bio4-campus-sign-mou-to-advance-precision-medicine-and-bioeconomy-collaboration-in-serbia/) - MultiOmic Health and BIO4 Campus announced the signing of a Memorandum of Understanding (MoU) to explore collaborative opportunities in biomedicine, biotechnology, and bioinformatics, with a strong emphasis on artificial intelligence (AI) applications.
- [MultiOmic Health and Alloy Therapeutics Collaborate to Discover and Develop Renal Tissue-Targeting Drugs](https://multiomic.health/multiomic-health-and-alloy-therapeutics-collaborate-to-discover-and-develop-renal-tissue-targeting-drugs/) - The collaboration provides external validation of MultiOmic Health’s AI-enabled precision medicine discovery platform and innovative renal therapeutic programs
- [Delivering precision medicines for chronic multifactorial diseases](https://multiomic.health/delivering-precision-medicines-for-chronic-multifactorial-diseases/) - MultiOmic Health is using a data-driven AI-enabled approach to develop tailored therapeutics for specific subpopulations of patients with metabolic syndrome-related conditions, which affect around half of the adult population worldwide.
- [MultiOmic Health presents at LSX Investival 2024](https://multiomic.health/multiomic-health-presents-at-lsx-investival-2024/) - Watch our CEO Robert Thong talk about how we are advancing precision medicine for metabolic-syndrome-related conditions at the LSX Investival Showcase in London.
- [MultiOmic Health announces discovery of novel endotypes and biomarkers for diabetic kidney disease](https://multiomic.health/multiomic-health-announces-discovery-of-novel-endotypes-and-biomarkers-for-diabetic-kidney-disease/) - MultiOmic Health, a leading AI-enabled drug discovery company, announces the identification of novel patient endotypes and the development of proprietary biomarkers for stratifying diabetic kidney disease (DKD) patients.
- [MultiOmic Health to Present at Bio€quity Europe 2024](https://multiomic.health/multiomic-health-to-present-at-bioequity-europe-2024/) - We're thrilled to announce our participation at #BioEquityEurope 2024! Robert Thong, our CEO at MultiOmic Health, will be presenting on our innovative approach to tackle cardiorenal complications. Join us for insights into how we aim to transform the landscape of metabolic syndrome through precision medicine.
- [MultiOmic Health and Queen’s University Belfast join forces to transform diabetic kidney disease diagnosis](https://multiomic.health/multiomic-health-and-queens-university-belfast-join-forces-to-transform-diabetic-kidney-disease-diagnosis/) - MultiOmic Health, an artificial intelligence (AI)-enabled drug discovery company, is embarking on a collaborative project with the Centre for Public Health at Queen's University Belfast (QUB) in Northern Ireland to develop data-driven diagnostic tools for Diabetic Kidney Disease (DKD).
- [A paper by the MultiOmic team members was published in the May issue of the ICT magazine](https://multiomic.health/a-paper-by-the-multiomic-team-members-was-published-in-the-may-issue-of-ict/) - What insight can recent trials give us into how molecular-level disease drivers can be used to enter into a new era of precision nephrology?
- [MultiOmic Health Closes $6.2 Million Funding Round to Discover Precision Medicines for Metabolic Syndrome-Related Conditions](https://multiomic.health/multiomic-health-closes-6-2-million-funding-round-to-discover-precision-medicines-for-metabolic-syndrome-related-conditions/) - MultiOmic Health has closed a £5 million seed extension round to build its precision therapeutics discovery platform for metabolic syndrome.
- [MultiOmic Health forges research collaboration with Northern Care Alliance NHS Foundation Trust in diabetic kidney disease](https://multiomic.health/multiomic-health-forges-research-collaboration-with-northern-care-alliance-nhs-foundation-trust-in-diabetic-kidney-disease/) - MultiOmic Health forges research collaboration with Northern Care Alliance NHS Foundation Trust in diabetic kidney disease
- [Honoured to be selected as winners of BIA's Innovation Showcase in the first ever TechBioUK conference](https://multiomic.health/honoured-to-be-selected-as-winners-of-bias-innovation-showcase-in-the-first-ever-techbiouk-conference/) - MultiOmic is proud to announce winning first place in the pitch competition at BIA's TechBio UK Conference 2022
- [Understanding the AI-enabled Drug Discovery Landscape](https://multiomic.health/understanding-the-ai-enabled-drug-discovery-landscape/) - An Expert View from Henrietta Bull, science and partnership analyst, and Robert Thong, chief executive, MultiOmic Health.
- [Leveraging AI to Tackle the Looming Metabolic Syndrome Crisis](https://multiomic.health/leveraging-ai-to-tackle-the-looming-metabolic-syndrome-crisis/) - In this article, we look at how Mesh Bio and MultiOmic Health use AI to transform and improve the lives of metabolic syndrome patients through patient stratification and precision medicine.
- [Leveraging deep omics data to tackle a global health challenge with precision](https://multiomic.health/nature-feature/) - We are excited to announce our feature in the most recent edition of Nature Portfolio's Biopharma Dealmakers discussing the advances in AI-driven drug development.
- [The Pharma Letter Podcast — Episode 15 — Can AI find new drugs for metabolic diseases?](https://multiomic.health/the-pharma-letter-podcast-episode-15-can-ai-find-new-drugs-for-metabolic-diseases/) - In this week's episode of The Pharma Letter Podcast, MultiOmic chief executive Robert Thong discusses his firm’s progress and ambitions for the future.
- [MultiOmic Health and Mesh Bio Partner to Use AI to Develop Precision Medicines and Diagnostics for Chronic Metabolic Disease](https://multiomic.health/multiomic-health-and-mesh-bio-partner-to-use-ai-to-develop-precision-medicines-and-diagnostics-for-chronic-metabolic-disease/) - MultiOmic Health and Mesh Bio announce their partnership to conduct an observational clinical study on patients with chronic metabolic disease.

## Pages

- [Home](https://multiomic.health/) - AI-Enabled Precision Medicine for Metabolic Syndrome
- [Team.](https://multiomic.health/team/) - TEAM. OPERATING TEAM Linkedin Robert Thong Co-founder & CEO 30+ years in biopharma & healthcare, focusing on R&D management, B2B partnerships and value creation strategy. Has engaged with over 100 organizations in biopharma, medical technology and healthcare. Published authority on biopharma R&D partnerships and biotech business models Linkedin Celia Schell CHIEF CLINICAL OFFICER &CHIEF OPERATING
- [Advisors.](https://multiomic.health/advisors/) - ADVISORS. SCIENTIFIC ADVISORS Linkedin Angeli Möller ROCHE PHARMACEUTICALS DIVISION, SWITZERLANDHead of Pharma International Informatics Alliance for Artificial Intelligence in Healthcare(AAIH) EXECUTIVE OFFICER & CO-FOUNDER Linkedin Richard Nkulikiyinka Antag TherapeuticsCHIEF MEDICAL OFFICER GenKardiaCHIEF DEVELOPMENT OFFICER FORMALLY AT BAYER VICE-PRESIDENT, HEAD OF THERAPEUTIC AREA CARDIOLOGY, NEPHROLOGY & PULMONOLOGY Linkedin Cristina Balagué ORIVA THERAPEUTICSCHIEF SCIENTIFIC OFFICER medibiofarma slDIRECTOR
- [Approach.](https://multiomic.health/approach/) - THE PROBLEM Half the world’s adult population are at risk of cardio-renal-metabolic disease For decades, the term metabolic syndrome described a clustering of abdominal obesity, insulin resistance, dyslipidemia, and hypertension. Today, science recognizes this cluster not as an isolated condition, but as an early expression of a broader, interconnected disease network. Current treatments are imprecise
- [Careers.](https://multiomic.health/careers/) - Careers. MULTIOMIC HEALTH OPEN POSITIONS We currently do not have any open positions, but please check back soon. Contact. Want to be a part of our team? Got a partnership in mind? Get in touch with us and know more about how we are changing the face of healthcare. THE COMPANY Multiomic Health Limited is a
- [Pipeline.](https://multiomic.health/pipeline/) - pipeline. MULTIOMIC HEALTH PIPELINE Active program pipeline advancing towards preclinical candidates all programs target dysfunctional pathways implicated in kidney inflammation and fibrosis (multiple aetiologies) Contact. Want to be a part of our team? Got a partnership in mind? Get in touch with us and know more about how we are changing the face of healthcare.
- [Board.](https://multiomic.health/board/) - THE BOARD. multiomic health board members Linkedin Robert Thong CO-FOUNDER, EXECUTIVE DIRECTOR & CEO 30+ years in biopharma & healthcare, focusing on R&D management, B2B partnerships and value creation strategy. Has engaged with over 100 organizations in biopharma, medical technology and healthcare. Published authority on biopharma R&D partnerships and biotech business models Linkedin Alasdair Thong
- [Privacy Notice.](https://multiomic.health/privacy-notice/) - PRIVACY NOTICE & COOKIE POLICY who we are MultiOmic Health Limited, a private limited company registered in England and Wales (CRN: 13246608). Our registered office is located at Epworth House, 25 City Road, Shoreditch, London, EC1Y 1AA. We are a computational systems biology company working towards improving the lives of patients with metabolic syndrome-related conditions.
- [Investors.](https://multiomic.health/investors/) - INVESTORS. MULTIOMIC HEALTH INVESTORS Ada Ventures Open to Possibility Fifty Years We’re founders, we back founders, and we’re backed by world-class founders. Formic Ventures Fighting Entropy, Putting Humans in Control of Their Own Destiny HOF Capital We help founders build enduring companies. Hoxton Ventures We back Europe's best tech companies, before the rest of the
- [Curiosity.](https://multiomic.health/curiosity/)

## Works

- [Selvedge Venture](https://multiomic.health/work/selvedge-venture/) - Selvedge Venture invests into founders and start ups with a mission to allieviate the titanic healthcare burden caused by age-related medical conditions. We invest into Pre-Seed, Seed and Series A ready companies across deep technology in life sciences and healthcare. Selvedge Venture’s core expertise is at the intersection of Biotechnology and Digital Technologies. We believe
- [PhD Studentship](https://multiomic.health/work/phd-studentship/) - Innovative multi-omics approaches to improve detection, diagnosis and prognosis of medical conditions and complications arising from metabolic syndrome Exciting PhD opportunity for an ambitious student to join a dynamic, enthusiastic research team at Queen’s University Belfast working together with scientists at Multiomic Health to drive forward research into medical conditions and complications arising from metabolic
- [Verve Ventures](https://multiomic.health/work/verve-ventures/) - Verve Ventures is a network and technology-driven venture capital firm based in Switzerland. Founded in 2010 by Steffen Wagner and Lukas Weber, Verve Ventures has grown to become one of the most active venture investors in Europe with around 150 science and technology-driven start-ups in its portfolio. The company invests from seed stage onward in
- [Hoxton Ventures](https://multiomic.health/work/hoxton-ventures/) - Hoxton Ventures is an early stage venture capital firm based in London and investing in European technology start-ups that can scale into large, global winners. It focuses on start-ups that either disrupt existing industries or invent entirely new market categories. It was the first institutional investor in Babylon Health, Darktrace and Deliveroo, and its portfolio
- [Ada Ventures](https://multiomic.health/work/ada-ventures/) - Ada Ventures is the inclusive venture capital firm rethinking venture capital by finding and funding extraordinary talent where others aren’t looking. It invests at pre-seed and seed across climate, economic empowerment, healthcare and ageing, supporting founders with breakthrough ideas for the hardest problems we face. Since its 2020 launch, the firm’s AUM now exceeds £100m,
- [MMC Ventures](https://multiomic.health/work/mmc-ventures/) - MMC Ventures is one of the most active early-stage tech investors in Europe. Our investment strategy is focused on enterprise AI, fintech, data-driven health, data infrastructure and cloud. For over two decades, we have partnered with founders from seed and series A stages to help them grow their start-ups. As a research-led investor, we have
- [Formic Ventures](https://multiomic.health/work/formic-ventures/) - We exist in a world filled with chaos, disorganization and irregularity. Technology, rather than taking control from us, is better used to empower people through valuable insights and in-depth understanding that augments and informs our decision making. Our mission is to provide people with the right tools to leverage technology and become more effective in
- [HOF Capital](https://multiomic.health/work/hof-capital/) - At HOF Capital, we are focused on supporting the world’s most brilliant, ambitious, and mission-driven founders — founders who are determined to improve the future of humanity through technological innovation while building massive, enduring companies that bring such innovation to market. It is in large part due to such founders that we now have the
- [Fifty Years](https://multiomic.health/work/fifty-years/) - Fifty Years is an early stage VC firm based in San Francisco. We’re backed by 44 founders of tech companies valued between $1B and $100B who want to help the next generation of founders change the world for the better. We call them the League of Giants because 50Y founders can stand atop their shoulders.

## Categories

- [News from the Team](https://multiomic.health/category/multiomicteam/)
- [News](https://multiomic.health/category/news/)
- [Blog Post](https://multiomic.health/category/blogpost/)
- [Articles](https://multiomic.health/category/articles/)
- [Press Release](https://multiomic.health/category/pressrelease/)
- [Interview](https://multiomic.health/category/interview/)
- [Podcast](https://multiomic.health/category/podcast/)

## Tags

- [Nature](https://multiomic.health/tag/nature/)
- [Feature](https://multiomic.health/tag/feature/)
- [Omics](https://multiomic.health/tag/omics/)
- [Precision Medicine](https://multiomic.health/tag/precision-medicine/)
- [MOHSAIC](https://multiomic.health/tag/mohsaic/)
- [Press Release](https://multiomic.health/tag/press-release/)
- [Multiomic Health](https://multiomic.health/tag/multiomic-health/)
- [Mesh Bio](https://multiomic.health/tag/mesh-bio/)
- [Partnership](https://multiomic.health/tag/partnership/)
- [Robert Thong](https://multiomic.health/tag/robert-thong/)
- [Podcast](https://multiomic.health/tag/podcast/)
- [The Pharma Letter](https://multiomic.health/tag/the-pharma-letter/)
- [AI](https://multiomic.health/tag/ai/)
- [Drug Discovery](https://multiomic.health/tag/drug-discovery/)
- [Metabolic Syndrome](https://multiomic.health/tag/metabolic-syndrome/)
- [BIA](https://multiomic.health/tag/bia/)
- [TechBio UK](https://multiomic.health/tag/techbio-uk/)
- [Conference](https://multiomic.health/tag/conference/)
- [NCA](https://multiomic.health/tag/nca/)
- [Fundraising](https://multiomic.health/tag/fundraising/)
- [Nephrology](https://multiomic.health/tag/nephrology/)
- [Clinical Trials](https://multiomic.health/tag/clinical-trials/)
- [Biomarkers](https://multiomic.health/tag/biomarkers/)
- [ICT](https://multiomic.health/tag/ict/)
- [CKD](https://multiomic.health/tag/ckd/)
- [Bio€quity Europe](https://multiomic.health/tag/bioequity-europe/)
- [DKD](https://multiomic.health/tag/dkd/)
- [LSX Investival](https://multiomic.health/tag/lsx-investival/)
- [Alloy Therapeutics](https://multiomic.health/tag/alloy-therapeutics/)
- [Collaboration](https://multiomic.health/tag/collaboration/)
- [Biopharmadealmakers](https://multiomic.health/tag/biopharmadealmakers/)
- [Chronic Multifactorial Diseases](https://multiomic.health/tag/chronic-multifactorial-diseases/)
- [BIO4](https://multiomic.health/tag/bio4/)

## Works Categories

- [Pre-Seed Investors](https://multiomic.health/work_genre/pre-seed-investors/)
- [MOH Jobs](https://multiomic.health/work_genre/jobs/)
- [Seed Investors](https://multiomic.health/work_genre/seed-investors/)